Dr Lorch (second from left) and Dr Täubel (third from left) visiting business partners in Japan

Our Managing Director Dr Jörg Täubel and Medical Director Dr Ulrike Lorch recently travelled to Japan to meet with business partners and learn more about the Japanese way of doing business.Nemawashi is a Japanese business process which assures a consensus and harmony between business partners. Nemawashi allows both parties to save valuable time before important meetings because both sides are able to adjust opinions and positions beforehand.

Dr Täubel (second from left) and Dr Lorch (third from left) visiting business partners in Japan

Dr Täubel and Dr Lorch gained first hand experience of Nemawashi during the week-long trip, during which time they met with a range of policy makers, media and business partners to gain further insights into the Japanese CRO and SMO markets.“The trip was a huge success” said Dr Lorch. “Not only did we hold very positive meetings with stakeholders, we also discovered a new and exciting way of life. I have started learning Japanese to help develop relations with our partners in future!”

Latest news

Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology

December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event